New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
3rd June 2024
1st February 2024
8th January 2024
26th July 2023
Mexico: The Federal Commission for the Protection against Public Health Risks (Cofepris) has seized 1,811 products from a number of stores in the Paradise chain in Mexico City, including CBD, hemp seeds, and cannabis extracts, for lacking sufficient safety evidence. Cofepris said some products displayed a false Cofepris registration code, violating regulations.
14th April 2023
12th April 2023
Mexico: President Andrés Manuel López Obrador has said 63 licences to distribute cannabis-based products that were issued by the Federal Commission for the Protection against Public Health Risks (Cofepris) to companies linked to the family of former president Vicente Fox are under investigation, press reports. López Obrador claims the licences were issued just five days before the end of the previous administration. Fox has denied any wrongdoing.
13th March 2023
3rd March 2023
6th February 2023
27th January 2023
23rd January 2023
Mexico: The president of the Board of Directors of the Senate, Alejandro Armenta, has told media that cannabis and hemp reform would be addressed in the upcoming legislative session that begins on 1st February. The Supreme Court of Mexico has been calling on Congress to legalise and regulate cannabis for years, repeatedly ruling that the country’s current cannabis laws are unconstitutional, but legislative efforts have failed year after year.
29th November 2022
Mexico: A court in Sonora has granted a citizen’s petition and ordered the Federal Commission for the Protection against Public Health Risks (Cofepris) to issue a permit to consume and cultivate recreational cannabis for personal use, press reports. No commercial activity is allowed under the order (called an amparo). While the regulatory landscape for cannabis in Mexico is very unsettled, the courts continue to grant amparos to companies and individuals for cannabis-related activities.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.